These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 878519

  • 1. [Iatrogenic kidney-calculi formation and kidney failure due to long-term treatment with calcinosis factors (dihydrotachysterol, vitamin D)].
    Gebhardt K.
    Z Arztl Fortbild (Jena); 1977 May 01; 71(9):447-9. PubMed ID: 878519
    [No Abstract] [Full Text] [Related]

  • 2. [Nil nocere. Renal calcinosis following long-term treatment with dihydrotachysterol].
    Stocker WG.
    Munch Med Wochenschr; 1972 Apr 07; 114(14):653-5. PubMed ID: 5067876
    [No Abstract] [Full Text] [Related]

  • 3. [Formation of urinary calculi due to overdosage of dihydrotachysterol].
    Lenk S, Brien G, Bick C.
    Z Arztl Fortbild (Jena); 1976 May 01; 70(9):470-1. PubMed ID: 936674
    [No Abstract] [Full Text] [Related]

  • 4. [Nephrocalcinosis caused by dihydrotachysterol therapy].
    Forsström J, Kasanen A, Sutinen S.
    Duodecim; 1971 May 01; 87(19):1331-6. PubMed ID: 5133057
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Dihydrotachysterol therapy for hypoparathyroidism: consequences of inadequate monitoring. Five cases and a review.
    Quack I, Zwernemann C, Weiner SM, Sellin L, Henning BF, Waldherr R, Büchner NJ, Stegbauer J, Vonend O, Rump LC.
    Exp Clin Endocrinol Diabetes; 2005 Jul 01; 113(7):376-80. PubMed ID: 16025398
    [Abstract] [Full Text] [Related]

  • 7. Treatment of vitamin D-resistant hypoparathyroidism with 25-hydroxycholecalciferol.
    Pak CY, DeLuca HF, Chavez de los Rios JM, Suda T, Ruskin B, Delea CS.
    Arch Intern Med; 1970 Aug 01; 126(2):239-47. PubMed ID: 4317441
    [No Abstract] [Full Text] [Related]

  • 8. Arrest of hyperparathyroid bone disease by the use of dihydrotachysterol in patients undergoing chronic hemodialysis.
    Kaye M, Chatterjee G, Cohen GF, Borra S, Sagar S.
    Trans Assoc Am Physicians; 1970 Aug 01; 83():245-53. PubMed ID: 5505392
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. ["Calcium gout" with nephrocalcinosis due to long-term dihydrotachysterine therapy].
    Schellhorn W.
    Med Klin; 1967 Aug 11; 62(32):1232-7. PubMed ID: 4298777
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Supplementation of vitamin D and calcium: advantages and risks.
    Díaz-López B, Cannata-Andía JB.
    Nephrol Dial Transplant; 2006 Sep 11; 21(9):2375-7. PubMed ID: 16766550
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Matrix stones.
    Allen TD, Spence HM.
    Trans Am Assoc Genitourin Surg; 1965 Sep 11; 57():77-83. PubMed ID: 5855566
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dihydrotachysterol (DHT) and supplemental calcium therapy in dialysis patients.
    Kliger AS, Yap P, Jensen P, Finkelstein FO.
    Proc Clin Dial Transplant Forum; 1965 Sep 11; 6():184-90. PubMed ID: 1029884
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [The metabolic effect of vitamins D in chronic renal insufficiency (author's transl)].
    Hrba J, Wilczek H, Pacovský V, Ston J.
    Sb Lek; 1975 Jul 11; 77(7):198-204. PubMed ID: 169565
    [No Abstract] [Full Text] [Related]

  • 20. [A case of nephrocalcinosis in AT 10 continuous medication].
    Aberle B.
    Wien Med Wochenschr; 1966 Jun 04; 116(23):524-5. PubMed ID: 5997677
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.